An observational study in COVID-19, sponsored by University of L'Aquila. Recruiting at 2 sites in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-05.
Sponsored by University of L'Aquila · Observational
People affected by SARS-CoV-2 infection, whether patients have developed mild forms or a severe form of the disease, complain of nonspecific and entirely new symptoms or complain about the persistence pf them.Investigators intend to follow over time the post-infectious phase of patients discharged from sub-intensive care unit. The aim is to identify symptoms and their frequency of presentation in the SARS-CoV-2 population in the post-acute period.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's planned enrollment of 100 is below the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →University of L'Aquila is the lead sponsor of 45 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients admitted to Ospedale San Salvatore dell'Aquila over 18 years during Sars-CoV2 pandemics, with or without Sars-CoV2 related disease
Exclusion Criteria:
Patients recovered from Sars-CoV2 infection
Other: Data collection
Patients who did not have Sars-CoV2
Other: Data collection
Data collection
Greater understanding of SARS-CoV-2 disease
Greater understanding of SARS-CoV-2 disease and its long-term manifestations. To this end, the clinical manifestations, any alterations in laboratory and instrumental parameters will be evaluated to identify organ damages and calculate its prevalence
Time frame: 24 months
Measurement of psychological impact of SARS-CoV-2 disease
Understanding the impact of the disease and its sequelae on daily life and the impact on the psychological aspect of the person;
Time frame: 24 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of L'Aquila